Latest issue of Hampshire & IOW Medicines Optimisation Bulletin
Written by AlisonFreemantle on Monday 12th February 2024
Issue 96 Provided by Hampshire & Isle of Wight ICB
The latest bulletin contains information on the following:
- MHRA Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate
- mega-3-acid ethyl ester medicines (Omacor/Teromeg 1000mg capsules): dose[1]dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors
- The British HIV Association (BHIVA) rapid guidance on the use of statins for primary prevention of cardiovascular disease (CVD) in people living with HIV
- UKHSA: Emergence of new Clostridioides difficile ribotype
- The NEWT Guidelines for swallowing difficulties
- National measles guidelines updated
- SPS: St. Mark’s electrolyte solution
- Menopause Pathway – Guidance on management and prescribing choices.
- Shortage of lidocaine 1% (or 2%) with adrenaline 1:200 000
- Levetiracetam granules
- Suspected sepsis: recognition, diagnosis and early management – updated guidance (NG51)
- Educational Webinar - medicines optimisation in people with a learning disability and/or autism
- Pharmacy First launches
- Emergency ordering service for community pharmacies for fidaxomicin to treat Clostridioides difficile infection (CDI)
Download the bulletin here for more information and links: